to minimize the chance of big cardiovascular activities like coronary heart assault, stroke, or Demise in adults with form two diabetic issues with known heart disease. The patent for semaglutide, the Lively ingredient in Ozempic and Wegovy, isn’t predicted to expire until all over 2031 within the earliest. adhere to us to stay up to date on a